Can BTSG Outgrow the $20B Acute Infusion Market on Volume Growth?
BrightSpring Health Services is gaining acute infusion share with 20%+ volume growth, targeting 12-15 new states in a $20 billion market.
Zacks Investment Research9/4/2026Positive
BTSG
BrightSpring Health Services, Inc. Common StockNASDAQHEALTHCAREHEALTH INFORMATION SERVICES
Key Statistics
Market Cap
$12.02B
P/E Ratio
54.22
EPS
$1.12
Beta
1.85
52W High
$73.75
52W Low
$25.06
50-Day MA
$65.10
200-Day MA
$50.12
Dividend Yield
—
Profit Margin
2.55%
Forward P/E
24.39
PEG Ratio
—
About BrightSpring Health Services, Inc. Common Stock
BrightSpring Health Services, Inc. (BTSG) is a leading provider of home and community-based health services, focusing on diverse patient populations, including individuals with intellectual and developmental disabilities and those in need of rehabilitation support. The company prioritizes personalized, high-quality care, facilitated by a dedicated and skilled workforce that significantly improves patient outcomes and quality of life. With robust investments in innovative technologies and a strong commitment to value-based care, BrightSpring is well-positioned to capitalize on growth opportunities within the dynamic healthcare landscape, highlighting its potential for sustainable, long-term success.
Fundamentals
| Revenue (TTM) | $14.37B |
| Gross Profit (TTM) | $1.78B |
| EBITDA | $626.82M |
| Operating Margin | 3.37% |
| Return on Equity | 13.00% |
| Return on Assets | 4.88% |
| Revenue/Share (TTM) | $70.11 |
| Book Value | $9.94 |
| Price-to-Book | 5.93 |
| Price-to-Sales (TTM) | 0.84 |
| EV/Revenue | 0.974 |
| EV/EBITDA | 22.99 |
| Quarterly Earnings Growth (YoY) | 196.60% |
| Quarterly Revenue Growth (YoY) | 23.00% |
| Shares Outstanding | $197.86M |
| Float | $150.40M |
| % Insiders | 3.13% |
| % Institutions | 108.38% |
Historical Volatility
HV 10-Day
48.59%
HV 20-Day
44.21%
HV 30-Day
73.36%
HV 60-Day
56.49%
HV Rank
97.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($78.94 target)
3
Strong Buy15
BuyLatest News
NVIDIA & 2 Profitable Stocks to Buy in September for Big Upside
NVDA's 63.7% net profit margin and 93.3% expected earnings growth put it among three profitable stocks positioned for market volatility.
Zacks Investment Research9/4/2026Neutral
Best Momentum Stocks to Buy for August 26th
BTSG, ANIK and OPHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 26th, 2026.
Zacks Investment Research8/26/2026Positive
New Strong Buy Stocks for August 26th
BTSG, OPHC, HRTG, UMC and MTG have been added to the Zacks Rank #1 (Strong Buy) List on August 26th, 2026.
Zacks Investment Research8/26/2026Positive
Zacks Industry Outlook CareDx, BrightSpring and PACS
CareDx, BrightSpring and PACS have been highlighted in this Industry Outlook article.
Zacks Investment Research8/25/2026Neutral
Sandisk & 2 Profitable Stocks to Buy Now for Explosive Upside
Sandisk, Celestica and BrightSpring rank among profitable stocks, with strong net income ratios and earnings growth supporting upside.
Zacks Investment Research8/24/2026Positive
3 Medical Service Stocks Resilient Amid Persistent Workforce Shortage
CareDx, BrightSpring and PACS Group are positioned for growth as digital health expands and workforce shortages reshape medical services.
Zacks Investment Research8/24/2026Positive
3 Non-Tech Thriving Nasdaq Stocks Enabling Its Northward Move in 2026
IBKR, ROKU and BTSG are thriving on Nasdaq, backed by product expansion, streaming growth and care migration.
Zacks Investment Research8/24/2026Positive
BrightSpring Stock Up Nearly 59% YTD: Can Its Growth Story Continue?
BTSG's nearly 59% YTD surge is backed by 23% revenue growth, rising margins and expansion in specialty pharmacy and home-based care.
Zacks Investment Research8/21/2026Positive
Here's Why You Should Add BrightSpring Stock to Your Portfolio Now
BTSG's specialty, infusion and home health momentum support growth, while IRA pressure and customer exits may weigh on near-term margins.
Zacks Investment Research8/12/2026Positive
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BTSG and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 9/7/2026